Analytical Data
-
Gene name
PLA2G3
- Application
-
Alternative Names
PLA2G3；Group 3 secretory phospholipase A2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NZ20
-
Expression Region
20-509aa
-
AA Sequence
G SPALRWYRTS CHLTKAVPGN PLGYLSFLAK DAQGLALIHA RWDAHRRLQS CSWEDEPELT AAYGALCAHE TAWGSFIHTP GPELQRALAT LQSQWEACRA LEESPAGARK KRAAGQSGVP GGGHQREKRG WTMPGTLWCG VGDSAGNSSE LGVFQGPDLC CREHDRCPQN ISPLQYNYGI RNYRFHTISH CDCDTRFQQC LQNQHDSISD IVGVAFFNVL EIPCFVLEEQ EACVAWYWWG GCRMYGTVPL ARLQPRTFYN ASWSSRATSP TPSSRSPAPP KPRQKQHLRK GPPHQKGSKR PSKANTTALQ DPMVSPRLDV APTGLQGPQG GLKPQGARWV CRSFRRHLDQ CEHQIGPREI EFQLLNSAQE PLFHCNCTRR LARFLRLHSP PEVTNMLWEL LGTTCFKLAP PLDCVEGKNC SRDPRAIRVS ARHLRRLQQR RHQLQDKGTD ERQPWPSEPL RGPMSFYNQC LQLTQAARRP DRQQKSWSQ
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PLA2G3, or Phospholipase A2 Group III, is an enzyme that plays a critical role in lipid metabolism and cell signaling. Recent studies have highlighted its significance in various physiological and pathological processes, including inflammation, cancer progression, and neurodegenerative diseases. PLA2G3 catalyzes the hydrolysis of phospholipids, leading to the production of free fatty acids and lysophospholipids, which serve as important signaling molecules that regulate cellular functions. Researchers have focused on recombinant PLA2G3 proteins to explore their structure-function relationships, potential therapeutic applications, and roles in disease mechanisms. The ability to produce recombinant PLA2G3 allows for detailed characterization of its enzymatic activity, substrate specificity, and interaction with other biomolecules, facilitating the study of its involvement in pathological conditions. Moreover, understanding the functional properties of this enzyme may pave the way for the development of novel therapeutic strategies targeting PLA2G3-related pathways. Overall, ongoing research into PLA2G3 and its recombinant proteins not only enhances our understanding of its biological significance but also opens new avenues for innovative treatments in various diseases.
